Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Motilent
London, England, United Kingdom
- Ownership
- Private
- Employees
- ~20
- Development stage
- Other
01
Overview
Motilent provides CE-marked and FDA-cleared quantitative MRI motility software (GIQuant) and a GI-focused imaging platform (Entrolytics) used in routine care, research, and clinical trials, particularly for assessing small bowel Crohn’s disease activity and other digestive diseases.[3][7]
- Therapeutic areas
- Women's HealthGastroenterology
- Modalities
- DeviceNon-pharmacological therapy
- Industry
- Digital Health Medical Devices
02
Partnerships
Minerva Imaging (strategic partnership for translational digestive disease research using preclinical and clinical imaging).[3]
Beyond the preview
Go deeper on Motilent.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Motilent.